Pharmaceutical manufacturing segment revenue of Fosun Pharmaceutical 2019-2022
In 2022, the Chinese pharmaceutical firm Fosun Pharmaceutical generated a revenue of almost 31 billion yuan from the pharmaceutical manufacturing segment. Overall, the pharmaceutical manufacturing sector had grown rapidly in recent years.